Trial NCT03151811

View at ClinicalTrials.gov 
Org. Study IDs: OP-103

Last trial update was posted on 2024-01-30

MeSH Interventions

Dexamethasone Dexamethasone acetate Melphalan Pomalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions


Stopping Reasons

Sponsor assessed all endpoints and collected Overall Survival data for another two years following the primary completion date of 03Feb2021.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID